<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
<url><loc>https://insightsemerge.com/press-releases/ambrosia-biosciences-announces-the-nonclinical-data-profiles-of-two-oral-small-molecule</loc><news:news><news:publication><news:name>Insights Emerge</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-15T14:26:04.464Z</news:publication_date><news:title>Ambrosia Biosciences Announces the Nonclinical Data Profiles of Two Oral Small Molecule Programs: A GLP-1 Receptor Agonist Intended for Once-Weekly Dosing and a GIP Receptor Antagonist</news:title></news:news></url>
<url><loc>https://insightsemerge.com/press-releases/lilly-to-present-new-data-across-zepbound-foundayo-eloratzp-and-retatrutide-at</loc><news:news><news:publication><news:name>Insights Emerge</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-14T17:13:29.209Z</news:publication_date><news:title>Lilly to present new data across Zepbound, Foundayo, EloraTZP and retatrutide at ObesityWeek 2026, moving obesity care beyond the scale</news:title></news:news></url>
<url><loc>https://insightsemerge.com/press-releases/innovent-announces-seven-innovative-products-including-mazdutide-and-pecondler</loc><news:news><news:publication><news:name>Insights Emerge</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-14T04:09:16.524Z</news:publication_date><news:title>Innovent Announces Seven Innovative Products Including Mazdutide and PECONDLE® Successfully Included in the 2026 National Reimbursement Drug List</news:title></news:news></url>
<url><loc>https://insightsemerge.com/press-releases/ionq-announces-executive-leadership-evolution</loc><news:news><news:publication><news:name>Insights Emerge</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-13T22:50:37.593Z</news:publication_date><news:title>IonQ Announces Executive Leadership Evolution</news:title></news:news></url>
<url><loc>https://insightsemerge.com/press-releases/accuray-closes-tcw-transaction-strengthening-balance-sheet-to-support-long-term-value</loc><news:news><news:publication><news:name>Insights Emerge</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-13T22:16:37.275Z</news:publication_date><news:title>Accuray Closes TCW Transaction, Strengthening Balance Sheet to Support Long-Term Value Growth</news:title></news:news></url>
<url><loc>https://insightsemerge.com/press-releases/beasley-broadcast-group-reports-third-quarter-revenue-of-dollar428-million</loc><news:news><news:publication><news:name>Insights Emerge</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-13T21:08:50.101Z</news:publication_date><news:title>BEASLEY BROADCAST GROUP REPORTS THIRD QUARTER REVENUE OF $42.8 MILLION</news:title></news:news></url>
<url><loc>https://insightsemerge.com/press-releases/dana-farber-cancer-institutes-molecular-biology-core-facilities-integrate-n6-iconpcr-into</loc><news:news><news:publication><news:name>Insights Emerge</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-13T18:00:45.108Z</news:publication_date><news:title>Dana-Farber Cancer Institute's Molecular Biology Core Facilities Integrate n6 iconPCR into Low-Input cfDNA Sequencing Service</news:title></news:news></url>
<url><loc>https://insightsemerge.com/press-releases/dr-carlo-bartoli-introduces-national-one-time-grant-to-support-clinical-innovation-in-us</loc><news:news><news:publication><news:name>Insights Emerge</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-13T17:25:03.688Z</news:publication_date><news:title>Dr. Carlo Bartoli Introduces National One-Time Grant to Support Clinical Innovation in U.S. Medical Education</news:title></news:news></url>
</urlset>